Redx Raises Funds And Remains Independent
Yesod Bid 'Substantially Undervalued' UK Biotech
Redx's takeover talks with a consortium led by controversial biotech veteran Sam Waksal, who was jailed for five years over his role in the ImClone stock scandal in 2003, have been terminated but the UK biotech has received a financial lifeline from Redmile and Sofinnova.